Hipoksi ile indüklenen faktör-1 alfa (HIF-1?) C111A gen polimorfizmi ile hemoglobin konsantrasyonu arasındaki ilişkinin araştırılması

Amaç: Sistemik hipoksiye karşı klasik fizyolojik cevap kırmızı kan hücresi üretimindeki artıştır. Hipoksi ile indüklenebilir faktörler (HIF), oksijen duyarlılık mekanizmasını ve hipoksik hücre metabolizmasını düzenlemektedirler. Son yıllardaki çalışmalar, HIF oksijen duyarlılık yolağındaki mutasyonların eritrositozun patogenezinde anahtar rol oynadığını göstermiştir. Bu çalışmamızda, transkripsiyonel aktiviteyi artırdığı bilinen HIF-1?'nın varyantı olan C111A gen polimorfizminin artmış hemoglobin konsantrasyonu ile muhtemel ilişkisini araştırmayı amaçladık. Materyal-Metot: Çalışmaya Isparta Süleyman Demirel Üniversitesi Tıp Fakültesi Hastanesi Poliklinik ve Servis'e müracat eden bireyler dahil edildi. Totalde 309, normal hemoglobine sahip 100 (Hgb17) denek vaka gurubu olarak bu çalışmada değerlendirildi. Genomik DNA örnekleri periferal kan lökositlerinden standart yönteme göre izole edildi. HIF-1? C111A tek nükleotid polimorfizmi için polimeraz zincir reaksiyonu-parça uzunluk polimorfizmi (PCR-RFLP) metodu uygulandı. Tüm bireyler için tam kan sayımı yapıldı. İstatistiksel analiz IBM SPSS Statistics 20 software, Hardy-Weinberg denge testi (HWE) ve bağımsız gruplarda t testi ile değerlendirildi. Bulgular: Vaka ve kontrol grubunda hem yaş (t= -2,80, p

Investigation of the relationship between hypoxia-induced factor-1 alpha (HIF-1?) C111A gene polymorphism and hemoglobin concentration

Aim: Classic physiological responses to systemic hypoxia are an increase in red blood cell production. Hypoxia inducible factors (HIFs), they are regulate the oxygen sensitivity mechanism and hypoxic cell metabolism. Recent works suggest that mutation of the HIF oxygen-sensing pathway plays a key role in the pathogenesis of the erythrocytosis. In the present study, the probable role of the polymorphic HIF-1? variant C111A, which is known to enhance transc riptional activity, was evaluated association with increased haemoglobin concentration. Materials and methods: Isparta Suleyman Demirel University Medical Faculty Hospital in the clinics and service subjects were included. A total of 309 subjects 100 (Hgb<17g/dl) with normal levels of haemoglobin 209 (Hgb>17g/dl) with high levels of Hgb were recruited for this study. Genomic DNA was extracted from peripheral blood leukocytes of all subjects. The polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method was performed for HIF1? C111A single nucleotide polymorphism (SNP). A complete blood count was performed for all subjects. . Data were evaluated by descriptive statistics, frequency analysis, Hardy-Weinberg equilibrium test and independent t test with SPSS 20.0 software. Results: In the case and control groups in terms of age (t= -2,80, p<0,05) and haemoglobin concentrations (t=30,50, p<0,05) were found to be statistically significant. Distribution of the genotype frequencies among the normal level Hgb and high level Hgb groups for C111A was calculated. The normal Hgb level group's genotype frequencies were 100, 0.00, and 0.00 for CC, CA, and AA, respectively CA and AA genotypes were not observed in both groups (p>0,05). As a result, no correlation between the nucleotide polymorphism C111A with a high concentration of Hgb.

___

  • 1. Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R, Maxwell P, Koch CJ, Ratcliffe P, Moons L, Jain RK, Collen D, Keshert E. Role of HIF-1? in hypoxia-mediated apoptosis, cell proliferation and tumor angiogenesis. Nature 1998;394:485-90.
  • 2. Laderoute KR, Amin K, Calaoagan JM, Knapp M, Le T, Orduna J, Foretz M, Viollet B. 5'- AMP-activated protein kinase (AMPK) is induced by low-oxygen and glucose deprivation conditions found in solidtumormicroenvironments. Mol Cell Biol. 2006;26:5336- 47.
  • 3. Wang GL, Semenza GL. Characterization of hypoxiainducible factor 1 and regulation of DNA binding activity by hypoxia. J. Biol. Chem. 1993;268(29):21513-8.
  • 4. Semenza GL. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol. 1999;15:551-78.
  • 5. Patiar S, Harris AL. Role of hypoxia-inducible factor-1? as a cancer therapy target. Endocrine-Related Cancer 2006;13:61-75.
  • 6. Semenza GL. Evaluation of HIF-1 inhibitors as anticancer agents. Cancer Lett 2007;12(19-20):853-59.
  • 7. Paez JG, Sellers WR. PI3K/PTEN/AKT pathway. Cancer Treat Res. 2003;115:145-67.
  • 8. Benoist B, McLean E, Egli I, Cogswell M. Worldwide prevalence of anemia 1993-2005, WHO Global Database on Anemia 2008.
  • 9. Wenger RH. Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression. Federation of American Societies for Experimental Biology 2002;16:1151-62.
  • 10. Narayan V. Iyer, Sandra W. Leung, Gregg L. Semenza. The Human Hypoxia-Inducible Factor 1? Gene:HIF1A Structure and Evolutionary Conservation. Genomics 1998;52:159-65.
  • 11. Konac E, Onen HI, Metindir J, Alp E, Asyali AB, Ekmekci A. An investigation of relationships between hypoxiainducible factor-1? gene polymorphisms and ovarian, cervical and endometrial cancers. Cancer Detection and Prevention 2007;31:102-9.
  • 12. Apaydin I, Konac E, Onen HI, Akbaba M, Tekin E, Ekmekci A. Single Nucleotide Polymorphisms in the Hypoxia-inducible Factor-1? (HIF-1?) Gene in Human Sporadic Breast Cancer. Archives of Medical Research 2008;39:338-45.
  • 13. Naidu R, Har YC, Taib NA. Associations between hypoxia-inducible factor-1 alpha (HIF-1alpha) gene polymorphisms and risk of developing breast cancer. Neoplasma 2009;56:441-7.
  • 14. Chachami G, Kalousi A, Papatheodorou L, Lyberopoulou A, Nasikas V, Tanimoto K, Simos G, Malizos NK, Georgatsou E. An Association Study between Hypoxia Inducible Factor-1alpha (HIF-1?) Polymorphisms and Osteonecrosis. Public Library of Science 2013;8(11):1- 8.
  • 15. Sharma S, Kapahi R, Sambyal V, Guleria K, Manjari M, Sudan M, Uppal MS, Singh NR. No Association of Hypoxia Inducible Factor-1? Gene Polymorphisms with Breast Cancer in North-West Indians. Asian Pac J Cancer Prev 2014;15(22):9973-78.